Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma

C.M.S. Tesileanu, M.J. Van den Bent, M. Sanson, W. Wick, A.A. Brandes, P.M. Clement, S.C. Erridge, M.A. Vogelbaum, A.K. Nowak, J.F. Baurain, W.P. Mason, H. Wheeler, O.L. Chinot, S. Gill, M. Griffin, L. Rogers, W. Taal, R. Ruda, M. Weller, C. McBainM.E. Van Linde, T.S. Sabedot, Y. Hoogstrate, A. Von Deimling, I. De Heer, W.F.J. Van IJcken, R.W.W. Brouwer, K. Aldape, R.B. Jenkins, H.J. Dubbink, J.M. Kros, P. Wesseling, K.J. Cheung, V. Golfinopoulos, B.G. Baumert, T. Gorlia, H. Noushmehr, P.J. French^*Show 18 moreShow less